What is the official website of CHANGE BIOTEC LIMITED ?

The official website of CHANGE BIOTEC LIMITED is www.changebiotec.com.

What is CHANGE BIOTEC LIMITED's cybersecurity risk score?

CHANGE BIOTEC LIMITED has an AI-generated cybersecurity risk score of 749 out of 1000, indicating a Moderate security posture according to Rankiteo's assessment.

How many security incidents has CHANGE BIOTEC LIMITED experienced?

According to Rankiteo, CHANGE BIOTEC LIMITED currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has CHANGE BIOTEC LIMITED been affected by any supply chain cyber incidents ?

According to Rankiteo, CHANGE BIOTEC LIMITED has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does CHANGE BIOTEC LIMITED have SOC 2 Type 1 certification ?

According to Rankiteo, CHANGE BIOTEC LIMITED is not certified under SOC 2 Type 1.

Does CHANGE BIOTEC LIMITED have SOC 2 Type 2 certification ?

According to Rankiteo, CHANGE BIOTEC LIMITED does not hold a SOC 2 Type 2 certification.

Does CHANGE BIOTEC LIMITED comply with GDPR ?

According to Rankiteo, CHANGE BIOTEC LIMITED is not listed as GDPR compliant.

Does CHANGE BIOTEC LIMITED have PCI DSS certification ?

According to Rankiteo, CHANGE BIOTEC LIMITED does not currently maintain PCI DSS compliance.

Does CHANGE BIOTEC LIMITED comply with HIPAA ?

According to Rankiteo, CHANGE BIOTEC LIMITED is not compliant with HIPAA regulations.

Does CHANGE BIOTEC LIMITED have ISO 27001 certification ?

According to Rankiteo,CHANGE BIOTEC LIMITED is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does CHANGE BIOTEC LIMITED operate in ?

CHANGE BIOTEC LIMITED operates primarily in the Biotechnology Research industry.

How many employees does CHANGE BIOTEC LIMITED have ?

CHANGE BIOTEC LIMITED employs approximately 8 people worldwide.

Does CHANGE BIOTEC LIMITED own any subsidiaries ?

CHANGE BIOTEC LIMITED presently has no subsidiaries across any sectors.

How many LinkedIn followers does CHANGE BIOTEC LIMITED have ?

CHANGE BIOTEC LIMITED's official LinkedIn profile has approximately 126,868 followers.

What is the NAICS classification code for CHANGE BIOTEC LIMITED ?

CHANGE BIOTEC LIMITED is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does CHANGE BIOTEC LIMITED have a Crunchbase profile ?

No, CHANGE BIOTEC LIMITED does not have a profile on Crunchbase.

Does CHANGE BIOTEC LIMITED have a LinkedIn profile ?

Yes, CHANGE BIOTEC LIMITED maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/change-biotec-limited.

How many cybersecurity incidents has CHANGE BIOTEC LIMITED experienced ?

As of August 13, 2026, Rankiteo reports that CHANGE BIOTEC LIMITED has not experienced any cybersecurity incidents.

How many peer or competitor companies does CHANGE BIOTEC LIMITED have ?

CHANGE BIOTEC LIMITED has an estimated 4,739 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

CBL

Boost Score +25 with badge (5 left)

749

/1000

Moderate

774

/1000

Fair

CHANGE BIOTEC LIMITED Vendor Cyber Rating & Cyber Score

changebiotec.com

Add Your Compliance Badge

We are an African Biotech Company Based in Nairobi Kenya. We are focused on the supply of Life Science solutions to Research institutions, Biotech startups, Hospitals, and similar clients.

CBL A.I CyberSecurity Scoring

Scoring History

CBL

CHANGE BIOTEC LIMITED CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

CBL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for CBL

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for CHANGE BIOTEC LIMITED in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for CHANGE BIOTEC LIMITED in 2026.

Incident Types CBL vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for CHANGE BIOTEC LIMITED in 2026.

Incident History - CBL (X = Date, Y = Severity)

Loading…

SUBSIDIARY

CHANGE BIOTEC LIMITED Subsidiaries

Parent Company

CBL

Biotechnology Research

Website: www.changebiotec.com

Company Size: 8

No subsidiary data available for this company.

Loading…

CHANGE BIOTEC LIMITED Similar Companies

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

Genentech

gene.com

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Loading…

NEWS

CHANGE BIOTEC LIMITED CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

March 31, 2026 08:30 PM

HUB Cyber Security Ltd. Announces Board Changes, Effective March 31, 2026

HUB Cyber Security Ltd. announced that Noah Hershcoviz has resigned from his position as a member of the Company?s Board of Directors,...

Read Article

May 20, 2024 07:00 AM

New Biotech Platforms Offer Better Paths to Biosecurity

Changes in uses of digital technology improved cybersecurity, offering a blueprint for making biotechnology more secure.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-71194

SUMMARY

In OpenStack Designate before 22.0.2, the mDNS handler performs pool-blind lookups when resolving record queries and NOTIFY requests. When two zones with the same name exist across different pools, the lookup fails with a deterministic error, causing the handler to return REFUSED for all DNS queries through that path. The _handle_notify path is exploitable via a single unauthenticated UDP packet. This is independently reachable through the cross-tenant zone overlap described in a different recent CVE, and also affects legitimate same-tenant cross-pool configurations. BIND9 views do not mitigate this issue as mDNS is a shared service upstream of any view configuration.

Published

Date2026-08-12

Updated

Date2026-08-12

RISK INFORMATION (Score: 6.8)

cvss3

Base Score: 6.8

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:N/I:N/A:H

Impact Score

Exploitability

2.2

REFERENCES

CVE-2026-71193

SUMMARY

In OpenStack Designate before 22.0.1, zone creation checks (_is_subzone, _is_superzone, and the duplicate-zone DB constraint) are scoped to the target pool only. An authenticated user can bypass these checks by scheduling a zone to a different pool via the AttributeFilter scheduler, creating an overlapping zone that conflicts with another tenant's zone. This enables cross-tenant DNS hijack (redirecting traffic to attacker-controlled IPs) and DNS denial of service (NODATA responses). Exploitation requires a multi-pool deployment with AttributeFilter enabled in scheduler_filters, which is a non-default but documented and supported configuration for self-service tiering.

Published

Date2026-08-12

Updated

Date2026-08-12

RISK INFORMATION (Score: 9.6)

cvss3

Base Score: 9.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:N/I:H/A:H

Impact Score

5.8

Exploitability

3.1

REFERENCES

CVE-2026-49481

SUMMARY

UpSnap is a wake on lan web app. Versions prior to 5.4.0 have an OS command injection vulnerability in the UpSnap’s device management functionality due to the presence of unsafe shell command template interpolation using the ip and the mac fields. User-controlled values can be inserted into the wake_cmd and shutdown_cmd templates and executed via /bin/sh -c (Linux) or cmd /C (Windows) without sanitization, resulting in an authenticated Remote Code Execution (RCE). A low-privileged user with permission to create or edit devices can execute arbitrary operating system commands on the UpSnap hosted server. Version 5.4.0 patches the issue.

Published

Date2026-08-12

Updated

Date2026-08-12

RISK INFORMATION (Score: 9.6)

cvss3

Base Score: 9.6

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:N

Impact Score

5.8

Exploitability

3.1

REFERENCES

CVE-2026-47718

SUMMARY

FUXA is a web-based Process Visualization (SCADA/HMI/Dashboard) software. When `secureEnabled=true`, FUXA `1.3.0-2773` still allows guest and invalid-token requests to read project, alarms, and scheduler APIs. Version 1.3.1 fixes this issue.

Published

Date2026-08-12

Updated

Date2026-08-12

RISK INFORMATION (Score: )

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-47717

SUMMARY

FUXA is a web-based Process Visualization (SCADA/HMI/Dashboard) software. In fuxa-server version 1.3.0, the GET /api/project endpoint exposes sensitive project configuration data to guest-context requests even when secureEnabled is enabled. Version 1.3.1 fixes the issue.

Published

Date2026-08-12

Updated

Date2026-08-12

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…